Home
Industry News

Clinical Lab Industry News

MRD testing helps clinicians track a patient's risk of cancer recurrence by detecting small traces of circulating tumor DNA (ctDNA) in a patient's bloodstream following treatment.

Labcorp Expands MRD Testing for Breast, Lung, and Colon Cancer Recurrence Risk

LabCorp

Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancer

MOBILion’s strategy is to integrate its HRIM technology across the mass spectrometry ecosystem, extending beyond proteomics into metabolomics, lipidomics, exposomics, and other high-value analytical markets.

MOBILion Systems Reports Proof-of-Concept Data Supporting a New Proteomics Approach

MOBILion Systems, Inc.

Peer-reviewed and collaborator studies indicate high-resolution ion mobility may address longstanding ion utilization limits in LC-MS proteomics workflows

Bladder cancer is among the most common and most expensive cancers to monitor, with an estimated 83,190 new US cases in 2024 and 800,000 living with the disease nationwide.

Cellens Secures $6.5M to Advance AI and Mechanobiology-Based Bladder Cancer Test

Cellens

The test leverages cellular biophysics and machine learning to offer a high-sensitivity alternative to traditional urine-based assays

FDA Clears Roche HER2 Tests to Expand Treatment Options in Metastatic Breast Cancer

Roche

Roche’s PATHWAY HER2 (4B5) test is the only test approved to identify all levels of HER2 expression

Photo of Sarah Tabrizi wearing a white laboratory coat and blue gloves while sitting at a laboratory bench.

10 People Who Shaped Science in 2025

Springer Nature

The annual “Nature’s 10” list captures how scientists pushed the boundaries of knowledge in 2025

STIs remain a largely silent epidemic, with 80 percent of chlamydia and gonorrhea infections going undiagnosed each year.

Collaboration Tackles Critical Gaps in US STI Diagnostics

Testmate Health, Intermountain Health

Intermountain Health’s support accelerates Testmate’s deployment of rapid molecular tests where patients often face delayed results or no access to lab-quality testing

The funded initiative will combine advanced AI, natural language processing, and secure AWS cloud infrastructure to provide access to contributions from institutions across Europe and Asia in their native languages.

AACR Project GENIE Receives 2025 AWS Imagine Grant to Advance Cancer Genomics Data for Clinical Research

American Association for Cancer Research

AI-powered, multilingual cancer research pipeline will accelerate the pace of global data curation and expand access to real-world clinical data

The Octave MSDA Test is the first and only clinically and analytically validated multi-analyte blood test that reports an MS disease activity score.

Nationwide Access to New Multi-Analyte Laboratory Test for Multiple Sclerosis

Quest Diagnostics, Octave Bioscience

Collaboration brings new hope for patients with multiple sclerosis through expanded access to a clinically validated multi-analyte blood test

Some 84 percent of researchers say they have used AI tools in their work but only 22 percent trust existing tools.

Elsevier Launches LeapSpace, an AI Workspace to Accelerate Lab Research

Elsevier

New platform combines millions of peer-reviewed studies with transparent AI tools to help researchers move from curiosity to discovery faster

Extracellular vesicles are nanometer-sized particles shed into body fluids, including blood and urine, that carry molecular information relevant to understanding, diagnosing, and treating cancer, degenerative diseases, and conditions in regenerative medicine.

Seed Funding Drives Development of Benchtop Exosome System for Precision Medicine

Hermes Biosciences

Hands-off isolation technology delivers higher yield and quality of extracellular vesicles, enabling reproducible workflows for clinical research and diagnostics

Prior to joining ADLM, Wells served for two years as CEO of the American College of Medical Genetics and Genomics (ACMG), and the ACMG Foundation for Genetic and Genomic Medicine (ACMGF).

ADLM Names Melanie J. Wells as CEO to Advance Innovation in Diagnostics

Association for Diagnostics and Laboratory Medicine

Wells will lead ADLM’s efforts to advance diagnostics, strengthen advocacy, and support laboratory professionals

New Research in Blood Cancer Diagnostics to Be Featured at AMP 2025

Association for Molecular Pathology

Studies reveal faster, more precise genetic testing tools for acute myeloid leukemia

In place of chemical H&E staining, ClearStain™ can preserve tissue for additional downstream assays, improve tumor purity, and lower sequencing failure rates.

AI-Powered Virtual Staining Brings Pathologists Closer to the Sequencing Bench

Pictor Labs

New virtual staining solution enhances molecular diagnostics performance, preserves tissue, and accelerates turnaround times

AI in Breast Cancer Risk Prediction: Clairity to Showcase New Research at RSNA 2025

Clairity

Clairity’s first FDA authorized AI platform for breast cancer prediction demonstrates consistent accuracy, real-world impact, and potential to transform global breast cancer screening

SEPSIS-SHIELD study validates TriVerity™ as a breakthrough test that can transform hospital triage by providing early clarity on both infection type and illness severity

Breakthrough Sepsis Test Could Save Lives and Billions by Catching the Infection Early

Inflammatix

Inflammatix cracks the code of sepsis with an AI-powered test that outperforms the standard of care

PHCbi’s live cell metabolic pathway analyzer, LiCellMo® recognized with an R&D100 Award.

PHC Corporation’s Biomedical Division Wins 2025 R&D 100 Award for LiCellMo Live Cell Metabolic Pathway Analyzer

PHC Corporation of North America

Designed to enhance understanding of cellular metabolic mechanisms, LiCellMo also improves reproducibility and quality of cell cultures

The new RESULTS Act would reform PAMA by dramatically improving the data used to set CLFS rates.

ACLA Applauds Introduction of RESULTS Act to Safeguard Seniors’ Access to Critical Diagnostic Tests

Today's Clinical Lab

Association relaunches ‘Stop Lab Cuts’ campaign to push for long-term Medicare payment reform

Emerging Technologies Guide: Fall 2025

Today's Clinical Lab

Recent new and emerging technologies in the field of laboratory medicine from the 2025 September Pathogen Detection & Infectious Disease issue of Today's Clinical Lab